1.Growth Inhibition of Tumor by Recombinant SEA
Quanbin XU ; Vanhong ZHANG ; Leilei ZHANG ; Chuanxuan LIU ; Qingjun MA
Chinese Journal of Cancer Biotherapy 1995;0(02):-
Objective:To evaluate the antitumor activity of recombinant SEA for therapy of B16 melanoma established in C57BL/6 mice. Methods:C57BL/6 mice with melanoma were treated with the purified rSEA. The tumors were isolated and weighted. Results:Tumor growth was apparently inhibited by rSEA at high, middle, and low doses intraperitone-ally, whose inhibition ratio were 79.3% , 75.6 % and 73. 8% respectively. rSEA treatment in situ could inhibit tumor growth more effectively(90.6% ). Further study showed that numerous CD8+ and CD4+ T cell were infiltrated in tumor tissues, which were consistent with tumor growth inhibition induced by rSEA. Conclusions: rSEA could inhibit tumor growth effectively, especially the treatment in situ. This study paves the way for tumor immunotherapy with targeted SEA.
2.Design and activity analysis of chimeric epidermal growth factor fusion vaccine E5T-mSEA.
Qingqing YIN ; Haiwei JIA ; Yanhong ZHANG ; Chuanxuan LIU ; Qingjun MA ; Buchang ZHANG ; Hui ZHONG ; Quanbin XU
Chinese Journal of Biotechnology 2010;26(3):357-362
Epidermal growth factor receptor (EGFR) and its ligands (EGF and TGFalpha) are over-expressed in a variety of tumors. Immunization EGF-carrier protein inhibits tumor growth through abrogating binding of EGF to EGFR. Here, a chimeric protein of EGF and TGFalpha (E5T) was genetically fused to Staphylococcal enterotoxin A (SEA), a bacterial superantigenic protein which promotes humoral B cell response through enhancement of Ag-specific CD4 T cells activity. The resulted fusion proteins were expressed in Escherichia coli and purified though metal chelating affinity chromatography. Immunization of E5T-mSEA fusion protein in mice induced production of high titers antibodies, which recognize both EGF and TGFalpha. Anti- E5T-mSEA serum at dilution of 1:10 significantly inhibited growth of A431 cell lines but had little effect on 293T cell lines.
Amino Acid Sequence
;
Animals
;
Cancer Vaccines
;
biosynthesis
;
immunology
;
Cell Line, Tumor
;
Enterotoxins
;
biosynthesis
;
genetics
;
Epidermal Growth Factor
;
biosynthesis
;
genetics
;
Escherichia coli
;
genetics
;
metabolism
;
Humans
;
Immunization
;
Mice
;
Mice, Inbred C57BL
;
Molecular Sequence Data
;
Random Allocation
;
Receptor, Epidermal Growth Factor
;
antagonists & inhibitors
;
immunology
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
;
Transforming Growth Factor alpha
;
biosynthesis
;
genetics